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Abstract: A series of amino acid conjugated diphenylmethylpiperazine 
derivatives were synthesized by coupling diphenylmethylpiperazine with 
different Boc-amino acids using EDCI/HOBt as coupling agent and NMM as 
base. The synthesized compounds were characterized by 1H-NMR and 
elemental analysis. The Boc-deblocked derivatives were tested for their 
antimicrobial activity. We are here reporting that Phe and Trp conjugated 
diphenylmethylpiperazine showed equally good antibacterial activities as that 
of conventional antimicrobial drugs. 
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Introduction 
Piperazine and their derivatives have their own importance in today’s drug discovery. 
Piperazine moiety certainly deserves the molecule backbone with versatile binding 
properties representing potent and selective ligands for a range of different biological targets 
in medicinal chemistry. Thus, piperazine is considered as honored scaffold. A number of 
substituted piperazines posses significant pharmacological action such as antihistamic1-2 
antimicrobial,3 acetylcholinesterae inhibitors4, antimalarial5,  dopamine transporter6-7, D2/D4 
antagonist8, MC4Receptor9, and HIV-protease inhibitor10-11. Under this category, 
benzhydrilpiperazine (diphenylmethylpiperazine) belongs to the diarylpiperazine family; 
possesses wide range of pharmacological properties such as anti-lipid-peroxidation 
activity12, antiallergic and antioxidant activity13 antihistamic activity14, myocardium-
inhibiting agent15 and antimicrobial activity16-17.  
 Currently there is a tendency to use amino acid/peptidyl residues during the prodrug 
design process. The literature reports that bioactive compounds show enhanced activity 
when linked to amino acids18-23. The  presence of an unusual  amino acid and  heterocyclic  
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building blocks has stimulated interest in new synthetic methodologies and strategies to 
obtain a target structure. In this connection, we have synthesized novel 
diphenylmethylpiperazine derivatives by the coupling of diphenylmethylpiperazine with 
various N-protected amino acids. The present study was undertaken with a view to find the 
efficacy of these diphenylmethylpiperazine derivatives as antimicrobial agents.         
Materials and methods 
All the amino acids used were of L-configuration unless mentioned. All Boc-amino acids 
and HOBt were purchased from Advanced Chem. Tech. (Louisville, Kentuky, USA). EDCI 
and NMM were purchased from Sigma Chemicals Co. (St. Louis, MO). All solvents and 
reagents used for the synthesis and analysis were of analytical grade. TLC was carried out 
on precoated silica gel plates (Merck) using chloroform/methanol/acetic acid (95:5:3) as an 
eluting system. 1H NMR spectra were obtained on a 300 MHz Bruker FT-NMR 
Spectrometer instrument by using CDCl3 as solvent and TMS as an internal standard. 
 The diphenylmethylpiperazine was synthesized as previously reported using standard 
procedure24. The compound 4 was coupled with different Boc-amino acids using 
EDCI/HOBt as coupling agent and NMM as base (Scheme 1).   
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Scheme 1. Reagents and conditions (a) NaBH4, methanol, r.t, 5 h (b) SOCl2, 
dichloromethane, 0-5 0C, 4 h (c) piperazine, K2CO3, DMF, 80 0C, 8 h. (d) EDCl, HOBt, 
NMM, DMF, 0 0C, 24 h. 
General procedure for the coupling of N-Boc amino acids with 
diphenylmethylpiperazine 
To the stirred solution of Boc-amino acid (2 mmol) and HOBt (0.31 g, 2 mmol) in DMF 
(10 mL) cooled to 0 ˚C, added NMM (0.22 mL, 2 mmol), EDCI (0.42 g, 2 mmol) and 
diphenylmethylpiperazine (0.5 g, 2 mmol). After 20 minutes, the pH of solution was adjusted to 8 
by the addition of NMM and the reaction mixture was stirred overnight while slowly warming to 
room temperature. The reaction mixture was quenched with water (2 mL) and the solvent was 
condensed. The residue was dissolved in chloroform (25 mL), washed with 5% NaHCO3 
(3 x 20 mL), H2O (1 x 20 mL) followed by 0.1N cold HCl (3 x 20 mL) and brine solution (3 x 
20 mL), dried over anhydrous Na2SO4. The chloroform was removed under reduced pressure to 
obtain the desired products. The analytical data of these compounds are presented in (Table 1).   
Where, R= Side chains of amiono acids 
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Table 1. Analytical data of the synthesized compounds. 
Elemental analysis, % Entry Side chain of amino 
acids (R) 
Yield 
% 
Molecular 
formula C H N 
1H-NMR (CDCl3), δ 
5a H
 
90 C24H31N3O3 
70.38 
(70.41) 
7.55 
(7.57) 
10.24 
(10.26) 
7.05-7.25 (m, 10H, Ar-H); 1.39 (s, 9H, Boc); 7.91 (s, 1H, 
NH-Boc); 4.62 (s, 1H, -CH-); 2.84 (s, 4H, -CH2-); 2.60 (s, 4H, 
-CH2-); 1.93 (s, 2H, αCH2). 
5b CH3
 
95 C25H33N3O3 
70.91 
(70.92) 
7.88 
(7.80) 
9.92 
(9.92) 
7.05-7.25 (m, 10H, Ar-H); 1.39 (s, 9H, Boc); 7.93(s, 1H, NH-
Boc); 4.62 (s, 1H, -CH-); 2.88 (s, 4H, -CH2-); 2.62 (s, 4H, -
CH2-); 4.33 (s, 1H, αCH); 1.25 (d, 3H, βCH3). 
5c 
CH3
CH3
 
93 C27H37N3O3 
71.83 
(71.84) 
 
8.22 
(8.20) 
 
9.30 
(9.31) 
 
7.05-7.27 (m, 10H, Ar-H); 1.39 (s, 9H, Boc); 7.90 (s, 1H, NH-
Boc); 4.65 (s, 1H, -CH-); 2.84 (s, 4H, -CH2-); 2.60 (s, 4H, -
CH2-); 4.51 (d, 1H, αCH-); 1.71 (m, 1H, βCH-); 1.25 (d, 6H, 
γCH3). 
5d C
H2
CH
CH3
CH3
 
91 C28H39N3O3 
72.25 
(72.26) 
 
8.42 
(8.40) 
 
9.02 
(9.03) 
 
7.09-7.23 (m, 10H, Ar-H); 1.43 (s, 9H, Boc); 7.90 (s, 1H, 
NH-Boc); 4.60 (s, 1H, -CH-); 2.85 (s, 4H, -CH2-); 2.49 (s, 4H, 
-CH2-); 4.50 (t, 1H, -αCH-); 1.90 (t, 2H, βCH2-); 2.00 (m, 1H, 
-γCH-); 1.43 (d, 6H, δCH3). 
5e 
H 2 C
 
85 C31H37N3O3 
74.52 
(74.54) 
 
7.39 
(7.41) 
 
8.42 
(8.41) 
 
7.06-7.45 (m, 15H, Ar-H); 1.43 (s, 9H, Boc); 7.98 (s, 1H, 
NH-Boc); 4.62 (s, 1H, -CH-); 2.90 (s, 4H, -CH2-); 2.62 (s, 4H, 
-CH2-); 4.52 (t, 1H, -αCH-); 3.19 (d, 2H, βCH2-). 
5f 
H2
C
C
H2
C O
O H2
C
 
90 C34H41N3O5 
70.21 
(70.22) 
 
7.04 
(7.05) 
 
7.24 
(7.23) 
 
7.04-7.37 (m, 15H, Ar-H); 1.43 (s, 9H, Boc); 7.80 (s, 1H, 
NH-Boc); 4.64 (s, 1H, -CH-); 2.85 (s, 4H, -CH2-); 2.54 (s, 4H, 
-CH2-); 4.41 (s, 1H, -αCH-); 1.89(q, 2H, - βCH2-); 2.16 (t, 2H, 
-γCH2-); 5.36 (s, 2H, CH2-). 
5g H2
C
C
H2
H2
C N
H
C
H2
H2
C
 
88 C35H46N4O3 
 
73.70 
(73.69) 
 
8.06 
(8.07) 
 
9.79 
(9.82) 
 
7.06-7.27 (m, 15H, Ar-H); 1.43 (s, 9H, Boc); 7.96 (s, 1H, 
NH-Boc); 4.54 (s, 1H, -CH-); 2.89 (s, 4H, -CH2-); 2.50 (s, 4H, 
-CH2-); 4.71 (t, 1H, -αCH-); 1.48 (q, 2H, βCH2-); 1.55 (q, 2H, 
γCH2-); 1.42 (q, 2H, δCH2-); 1.39 (t, 2H, εCH2-); 1.95 (s, 1H, 
NH); 3.75 (d, 2H, CH2). 
        
       
 
5h 
H2
C
C
H2
H2
C
N
H
N
H
NO2
NH
 
90 C27H39N7O5 
59.88 
(59.85) 
 
7.20 
(7.19) 
 
18.14 
(18.12) 
 
7.08-7.25 (m, 10H, Ar-H); 1.43 (s, 9H, Boc); 8.00 (s, 1H, 
NH-Boc); 4.73 (s, 1H, -CH-); 2.88 (s, 4H, -CH2-); 2.59 (s, 4H, 
-CH2-); 4.54 (t, 1H, -αCH-);  1.32 (q, 2H, βCH2-); 1.33 (q, 
2H, γCH2-); 2.59 (t, 2H, δCH2-); 2.0 (m, 3H, guanidine). 
5i 
NN
H2C
H2
C
O
H2
C
 
90 C36H43N5O4 
70.90 
(70.93) 
 
7.04 
(7.06) 
 
11.48 
(11.49) 
 
7.04-7.35(d, 15H, Ar-H); 1.43 (s, 9H, Boc); 8.00 (s, 1H, NH-
Boc); 4.54 (s, 1H, -CH-); 2.90 (s, 4H, -CH2-); 2.50 (s, 4H, -
CH2-); 4.70 (s, 1H, -αCH-); 3.12 (s, 2H, - βCH2-); 6.55 (s, 2H, 
imidazole); 4.60 (s, 2H, CH2); 5.61 (s, 2H, CH2). 
5j 
H2C
HN
 
92 C33H38N4O3 
73.59 
(73.60) 
 
7.07 
(7.06) 
 
10.39 
(10.40) 
 
7.04 - 7.30 (m, 14H, Ar-H); 1.43 (s, 9H, Boc); 7.80 (s, 1H, 
NH-Boc); 4.69 (s, 1H, -CH-); 2.92 (s, 4H, -CH2-); 2.48 (s, 4H, 
-CH2-); 4.58 (s, 1H, -αCH-); 3.19 (d, 2H, βCH2-); 10.12 (d, 
1H, NH of indole); 6.81 (d, 1H, -CH-). 
5k 
C
H2
C NH2
O
 
94 C26H34N4O4 
66.92 
(66.95) 
 
7.31 
(7.30) 
 
12.00 
(12.01) 
 
7.04-7.19 (d, 10H, Ar-H); 1.45 (s, 9H, Boc); 7.98 (s, 1H, NH-
Boc); 4.67 (s, 1H, -CH-); 2.90 (s, 4H, -CH2-); 2.60 (s, 4H, -
CH2-); 4.48 (t, 1H, -αCH-); 2.81 (t, 2H, (CO)CH2 -); 6.00 (s, 
2H, NH2). 
5l 
N
 
89 C27H35N3O3 
72.15 
(72.16) 
 
7.81 
(7.80) 
 
9.34 
(9.35) 
 
7.05-7.22 (m, 10H, Ar-H); 1.43 (s, 9H, Boc); 4.65 (s, 1H, -
CH-); 2.88 (s, 4H, -CH2-); 2.55 (s, 4H, -CH2-); 1.73 (t, 2H, -
CH2); 1.48 (q, 2H, CH2); 3.1 (t, 2H, -CH2); 3.9 (t, 1H, -CH-). 
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Deprotection of Boc group 
The Boc group was deblocked by treating the protected compounds (1 mmol) with 4 N HCl 
in dioxane (10 mL / g of the compound) for 1.5 hours. Excess HCl and dioxane were 
removed under reduced pressure, triturated with ether, filtered, washed with ether and dried 
(yield, 100%).    
Antimicrobial assay 
Antibacterial activity 
In vitro antibacterial assays were performed against Staphylococcus aureus, E coli, Klebesiella 
pnemoniae and Pseudomonas auregenosa by using agar well diffusion method25. All the 
synthesized compounds were tested in triplicate, streptomycin was used as positive control and 
water as negative control. The zone of inhibition area was measured in mm (Table 2). 
Antifungal activity 
 In vitro antifungal assays were performed against Aspergillus niger, Aspergillus flavus and 
Fusarium monoliforme by using agar well diffusion method.26 The fungicidal activity of the 
synthesized compounds was assessed by comparing the zone of fungal growth in treated 
plates with that of control plates in mm (Table 2).  
Table 2. Antibacterial and antifungal activity of the synthesized compounds against various 
bacterial and fungal strains. 
Inhibitory Zone (diameter) mm b 
  
Bacterial Strains Fungal Strains 
Compoundsa Staphylococcus  
aureus 
 E.coli Klebesiella 
pnemoniae 
 Pseudomonas 
auregenosa 
 Aspergillus            
niger 
Aspergillus                                                   
flavus 
Fusarium        
monoliforme 
4 04 03 03 04 02 04 05 
5a 08 08 05 06 05 04 05 
5b 07 08 06 07 06 05 04 
5c 09 08 07 08 02 07 05 
5d 09 08 09 10 06 06 05 
5e 13 13 12 11 06 07 05 
5f 10 09 09 08 07 05 07 
5g 07 07 06 07 05 03 03 
5h 07 06 05 06 05 06 04 
5i 10 09 07 09 07 08 07 
5j 12 12 11 14 05 07 06 
5k 05 04 05 06 04 05 06 
5l 07 06 07 08 06 05 06 
Streptomycin 12 12 10 11 -- -- -- 
 Bavistin             --     --         --            -- 09 10 09 
a
 Concentration of compounds and reference drug: 10 µg per well. b Values are means of three 
determinations, the ranges of which are less than 5% of the mean in all cases. 
Results and Discussion 
We have synthesized new class of diphenylmethylpiperazine derivatives 5(a-l) by coupling 
of diphenylmethylpiperazine with N-protected Boc-amino acids using EDCI as a coupling 
agent, HOBt was used to avoid the racemization at the C-terminal amino acids, NMM was 
used to maintain the pH to 8. The product obtained was gummy and characterized by TLC, 
elemental analysis and 1H NMR. 
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 All the synthesized compounds 5(a-l) showed antibacterial activity against strains of 
both gram +ve and gram -ve bacteria such as Staphylococcus aureus, Klebesiella 
pnemoniae, Pseudomonas auregenosa and E coli and showed antifungal activity was against 
Aspergillus niger, Aspergillus flavus and Fusarium monoliforme. Among the synthesized 
compounds 5e and 5j showed equally good antibacterial activity as that of conventional 
antimicrobial drugs. Their enhancement of antibacterial activity may be due to the presence 
of aromatic and heterocyclic moiety of the amino acid residues. Even though amino acids 
and diphenylmethylpiperazine which taken in isolation were inactive or weakly active 
towards these bacterial strains, synthesized compounds showed activity.  
Conclusion 
In an effort to discover new diphenylmethylpiperazine analogues as antimicrobial molecule, 
we found that compounds 5e and 5j showed good antibacterial activity and all other 
compounds showed a moderate activity. But conversely some of the compounds 5i, 5e, 5f and 
5j showed moderate antifungal activity and the remaining showed a mild antifungal activity. 
The results of the present study indicate that compounds 5i, 5j, 5e and 5f might be of interest 
for the identification of new antimicrobial molecules. Further work on conjugation of aromatic 
and heterocyclic moiety to the diphenylmethylpiperazine is in progress. 
Acknowledgement 
The authors wish to thank UGC New Delhi, CSIR New Delhi, Lady Tata Memorial Trust 
Mumbai and University of Mysore, Mysore for their financial assistance. 
References 
1. Gyoten M, Nagaya H, Fukuda S, Ashida Y and Kawano Y, Chem Pharm Bull Tokyo, 
2003, 51(2), 122-133. 
2. Magid A  G, John A, Moyer Susan T N, Michael W and Usha P, J Med Chem., 1995, 
38, 4026-4032.  
3. Chaudhary P, Kumar R, Verma A K, Singh D, Bioorg  Med Chem., 2006, 14, 1819-1826.  
4. Hachiro S, Hiroo O, Yasuo A, Youichi I. and Yoshiharu Y, Japanese J Pharmacol., 
2002, 89(1), 7-20.  
5. Rebecca D P and Patricia M, Combinatorial Chemistry & High Throughput 
Screenings, 2005, 8, 39-48. 
6. Makoto K, Tomoko M, Koji Y, Masaki M, Nobuo K, Nobuyuki K, Kenichi K, 
Masato I, Yuji K, Katsuji O and Takayuki N, Bioorg & Med Chem., 2003, 11, 3953-3963. 
7. Makoto K, Tomoko M, Koji Y, Masaki M, Nobuo K, Nobuyuki K, Kenichi K, 
Masato I, Yuji K, Katsuji O and Takayuki N, Bioorg & Med Chem., 2004, 12, 3069-3078. 
8. He Zhao, Xiaoshu He, Andrew T, Diane H, Andrzej K, Robbin B, Renee P and Jan W 
F, Bioorg & Med Chem Lett., 2002, 12, 3111-3115. 
9. Brian D, Jessica P, Teresa P, Lee C, Brian M, Robin S, Julia H, Tracy B, Mary C, 
John S and Val G, Bioorg & Med Chem Lett., 2003, 13, 3793-3796. 
10. Rossen K, Steven A W, Sager J, Reamer R A, Askin D, Volante R P and Reider P J, 
Tetrahedron Lett., 1995, 36, 6419-6422. 
11. David A, Kan K E, Kai R, Robert M P, Kenneth M W, Volante R P and Paul J R, 
Tetrahedron Lett., 1994, 35(5), 673-676. 
12. Kawasaki N, Miyataka H, Nishiki M, Matsumato H, Inagaki N, Nagai H and Satoh T,  
Chem Pharma Bull., 1999, 47(2), 177-181.  
13. Sugiyama N, Akahoshi S, Kuwahara M, Kajii, J Med Chem., 1994, 37, 1977-1982. 
Synthesis and Antimicrobial Activity of Amino Acids S479 
14. Kumagai, US Patent, 1995, 5, 432, 179.  
15. Kaneko, US Patent, 1994, 5, 304, 558.  
16. Yung D K, Gilroy M L and Mahony D E, J Pharm Sci., 1978, 67(7), 900-905.  
17. Yung D K, Mahony D E and Whitehouse L W, J Pharm Sci., 1971, 60(3), 386-389. 
18. Suryanarayana V, Sandeep S, Menakshi J, Savitha S, Prati Pal S, Chaman Lal K and 
Rahul Jain, Bioorg  Med Chem., 2004, 12, 239-247.  
19. Sudhir R G, Rangan S R S, Krishna C A, J Med Chem., 1990, 33(5), 1505-1510. 
20. Prasun K C, Philip L C, Michael J W, John A K, J Med Chem., 1983, 26, 633-638. 
21. Ana C L L, Kezia P S, Ivone ADS, Janete M D A and Dalci J B,  Eur J Med Chem., 
 2004, 39, 1059-1065. 
22. Christian A, Emmanuelle V, Helene B, Claude P, Jean B, Bernard M, J Med Chem., 
1984, 27, 1161-1166. 
23. Hiroshi I, Maiko M, Boonma L and Tomoyo M, Int J Biol Macromol, 1995, 17(1), 21. 
24. Song K S, Lee S H, Chun H J, Kim J Y,  Jung M E,  Ahn K, Kim S and lee J, Bioorg 
Med Chem., 2008, 16, 4035- 4051. 
25. Perez C, Paul M and Bazerque P, Acta Biol Med Exp. 1990, 15, 113-115. 
26.  Singh I and Singh VP, Phytomorphology, 2000, 50(2), 151-157. 
 
 
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Inorganic Chemistry
International Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
 International Journal ofPhotoenergy
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Carbohydrate 
Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Physical Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com
 Analytical Methods 
in Chemistry
Journal of
Volume 2014
Bioinorganic Chemistry 
and Applications
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Spectroscopy
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Medicinal Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Chromatography  
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Applied Chemistry
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Theoretical Chemistry
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Spectroscopy
Analytical Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Quantum Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Organic Chemistry 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Catalysts
Journal of
Electrochemistry
International Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
